Blog

The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of approximately $2.2 million and increased approximately 10% versus net Q2 2024 revenue of approximately $2.7 million

Mytesi prescription volume increased approximately 6.5% in Q2 2025 over Q1 2025 and Mytesi prescription volume in Q2 2025 was equal to the volume in Q2 2024

As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in US

Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar’s orphan indication products, resulting in non-dilutive funding for Jaguar

REMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q2 2025 financials and company updates; Click here to register

SAN FRANCISCO, CA / ACCESS Newswire / August 14, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today reported its consolidated second-quarter 2025 financial results.

2025 SECOND QUARTER COMPANY FINANCIAL RESULTS:

• Neonorm^™: Revenues for the non-prescription Neonorm products were minimal for the second quarters of 2025 and 2024.

		Three Months Ending
Financial Highlights		June 30,
(in thousands, except per share amounts)		2025				2024				$ change				% change
Net product revenue		$	2,979			$	2,721				258				9	%
Loss from operations		$	(8,007	)		$	(7,197	)			(810	)			11	%
Net loss attributable to common stockholders		$	(10,406	)		$	(9,492	)			(914	)			10	%
Net loss per share, basic and diluted		$	(10.25	)		$	(2.66	)			(8	)			285	%

• Non-GAAP Recurring EBITDA: Non-GAAP recurring EBITDA for the second quarters of 2025 and 2024 were a net loss of $7.9 million and $8.8 million, respectively.

		Three Months Ending
		June 30,
(in thousands)		2025				2024				$ change				% change
		(unaudited)
Net loss attributable to common stockholders		$	(10,406	)		$	(9,492	)			914				-10	%
Adjustments:
Interest income			(15	)			(108	)			(93	)			86	%
Property and equipment depreciation			16				17				1				4	%
Amortization of intangible assets			427				430				3				1	%
Share-based compensation expense			279				387				109				28	%
Loss on extinguishment of debt			1,822				–				(1,822	)			-100	%
Non-GAAP EBITDA			(7,877	)			(8,766	)			(888	)			10	%

Note Regarding Use of Non-GAAP Measures

The Company supplements its condensed consolidated financial statements presented on a GAAP basis by providing non-GAAP EBITDA and non-GAAP recurring EBITDA, which are considered non-GAAP under applicable SEC rules. Jaguar believes that the disclosure items of these non-GAAP measures provide investors with additional information that reflects the basis upon which Company management assesses and operates the business. These non-GAAP financial measures are not in accordance with GAAP and should not be viewed in isolation or as substitutes for GAAP net sales and GAAP net loss and are not substitutes for, or superior to, measures of financial performance in conformity with GAAP.

The Company defines non-GAAP EBITDA as net loss before interest expense and other expense, depreciation of property and equipment, amortization of intangible assets, share-based compensation expense and provision for or benefit from income taxes. The Company defines non-GAAP Recurring EBITDA as non-GAAP EBITDA adjusted for certain non-recurring revenues and expenses. Company management believes that non-GAAP EBITDA and non-GAAP Recurring EBITDA are meaningful indicators of Jaguar’s performance and provide useful information to investors regarding the Company’s results of operations and financial condition.

Participation Instructions for Webcast

When: Thursday, August 14, 2025 at 8:30 a.m. Eastern

Participant Registration & Access Link: Click Here

Replay Instructions for Webcast

Replay of the webcast on the investor relations section of Jaguar’s website: (click here)

About Crofelemer

Crofelemer is the only oral FDA-approved prescription drug under botanical guidance. It is plant-based, extracted and purified from the red bark sap of the Croton lechleri tree in the Amazon Rainforest. Napo Pharmaceuticals, a Jaguar family company, has established a sustainable harvesting program, under fair trade practices, for crofelemer to ensure a high degree of quality, ecological integrity, and support for Indigenous communities.

About the Jaguar Health Family of Companies

Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo’s crofelemer is FDA-approved under the brand name Mytesi^® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

For more information about:

Jaguar Health, visit https://jaguar.health

Napo Pharmaceuticals, visit www.napopharma.com

Napo Therapeutics, visit napotherapeutics.com

Magdalena Biosciences, visit magdalenabiosciences.com

Canalevia-CA1, visit canalevia.com

Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram

About Mytesi^®

Mytesi (crofelemer) is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

See full Prescribing Information at Mytesi.com. Crofelemer, the active ingredient in Mytesi, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.

About Gelclair^®

INDICATIONS

GELCLAIR^® has a mechanical action indicated for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies, including oral mucositis/stomatitis (may be caused by chemotherapy or radiation therapy), irritation due to oral surgery, traumatic ulcers caused by braces or ill-fitting dentures, or disease. Also, indicated for diffuse aphthous ulcers.

IMPORTANT SAFETY INFORMATION

• Do not use GELCLAIR if there is a known or suspected hypersensitivity to any of its ingredients.

• No adverse effects have been reported in clinical trials, although postmarketing reports have included infrequent complaints of burning sensation in the mouth.

• If GELCLAIR is swallowed accidentally, no adverse effects are anticipated.

• If no improvement is seen within 7 days, a physician should be consulted.

You are encouraged to report negative side effects of prescription medical products to the FDA.

Visit www.fda.gov/safety/medwatch, call 1-855-273-0468 or fill-in the form at this link.

Please see full Prescribing Information at:

https://www.gelclairhcp.com/pdf/prescribing-information-instructions-for-use.pdf

Important Safety Information About Canalevia^®-CA1

For oral use in dogs only. Not for use in humans. Keep Canalevia-CA1 (crofelemer delayed-release tablets) in a secure location out of reach of children and other animals. Consult a physician in case of accidental ingestion by humans. Do not use in dogs that have a known hypersensitivity to crofelemer. Prior to using Canalevia-CA1, rule out infectious etiologies of diarrhea. Canalevia-CA1 is a conditionally approved drug indicated for the treatment of chemotherapy-induced diarrhea in dogs. The most common adverse reactions included decreased appetite, decreased activity, dehydration, abdominal pain, and vomiting.

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Use only as directed. It is a violation of Federal law to use this product other than as directed in the labeling.Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.

See full Prescribing Information at Canalevia.com.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements.” These include statements regarding Jaguar’s expectation that it will hold an investor webcast on August 14, 2025, and statements regarding Jaguar’s planned regulatory pathway to complete a supplemental NDA for crofelemer for patients with metastatic breast cancer. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:
hello@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

View the original press release on ACCESS Newswire

17 Total Broadcasts, Including Regular-Season and Preseason Games, will air on the stations in addition to streaming on Victory+

DALLAS, TX / ACCESS Newswire / August 14, 2025 / Victory+™ is excited to announce a new broadcast partnership with KDFW FOX 4 and KDFI More 27, bringing more Dallas Stars action to local TV viewers as the team builds from a spectacular 24/25 season. The arrangement will see a total of 17 Dallas Stars NHL games, including 15 regular-season games and 2 preseason matchups, airing across the local stations, giving Stars fans more ways to join in the action.

KDFW FOX 4 will air 9 games, and KDFI More 27 will air 8 games, with exact matchups and dates to be confirmed.

As Victory+ approaches its one– year anniversary, Texas sports fans have much to celebrate as, in addition to streaming Dallas Stars and Texas Rangers games, Victory+ recently announced the addition of Texas High School Football, including a game of the week and the State Championships for free.

“More access to more fans is at the core of what Victory+ offers, and we’re thrilled to expand our relationship with FOX 4 and KDFI to offer 17 Dallas Stars games to the local community,” said Neil Gruninger, President & CEO of APMC, parent company of Victory+. “This collaboration helps bring the excitement of Stars hockey into fans’ homes, and we’re proud to offer this as we continue to grow and engage with our audience.”

“Following the success of last season’s partnership with Victory+, we are pleased that this season we can provide local fans with the chance to see significantly more Stars action,” said Jeff Gurley, SVP and General Manager of KDFW FOX 4 and KDFI More 27. “This is a natural addition to our already strong coverage of the team, in an effort to serve the passionate Dallas hockey community who deserves it.”

“We’re excited to see the Stars’ continued success on Victory+ and to expand access for our fans in Dallas,” added Brad Alberts, President & CEO of the Dallas Stars. “Working with FOX 4 and KDFI gives our fans another platform to catch our games, and we’re thrilled to continue growing our audience together.”

This new deal reinforces the commitment to offering local viewers enhanced access to premium sports content as the Dallas Stars aim for a strong season and a deep playoff run.

ABOUT APMC and Victory+

A Parent Media Co. Inc. (APMC) is a media and technology company focused on providing innovative solutions to consumers and brands. APMC is a leader in Safe Streaming™ delivering an end-to-end solution to brands and platforms with an emphasis on unlocking incremental revenue. Utilizing proprietary streaming and monetization technologies, APMC reaches millions of homes globally through its products including Kidoodle.TV®, Dude Perfect Streaming Service, Glitch+™, Victory+™ and Safe Exchange™. Victory+ a groundbreaking FREE end-to-end, direct to consumer, sports streaming service made for fans, by fans. Featuring free regional broadcasts of various sports teams including the Dallas Stars, Anaheim Ducks, and Texas Rangers. Victory+ is also the home to a library of on-demand, premium sports-based, outdoors, and extreme sports content. Visit www.aparentmedia.com and www.victoryplus.com to learn more.

LinkedIn: linkedin.com/company/aparentmediacoinc

X: https://x.com/aparentmediaco

Media Contact:

Contact | media@aparentmedia.com

SOURCE: A Parent Media Co. Inc.

Related Images

View the original press release on ACCESS Newswire

Comparable clinic revenues increase 5.7% vs prior year period

Net losses decrease 10% vs. prior year period

VIRGINIA BEACH, VA / ACCESS Newswire / August 14, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today reported financial results for the second quarter ended June 30, 2025.

Second Quarter 2025 Financial Highlights Compared to Prior Periods

• Total revenue of approximately $4.3 million, a sequential increase of 20% from Q1 2025 and a decrease of 2% from the prior year period. The decrease in revenue is attributed to the exclusion of the Hawaii clinic (KVC) from 2025 results

• Services revenue of approximately $3.2 million, a sequential increase of 17% from Q1 2025 and a decrease of 1% from the prior year period

• Product revenue of $1.1 million, a sequential increase of 21% from Q1 2025 and a decrease of 7% from the prior year period

• Comparable clinic revenues increased 5.7% from the prior year period

• Total operating expenses of $6.2 million, an increase of 5% from the prior year period

• Net loss of $3.0 million, a decrease of $0.4 million from the prior year period

• Entered an exclusive, non-binding Letter of Intent to acquire 100% ownership interest in one animal hospital located in New Jersey. Once completed, the acquisition could potentially add up to approximately $2.0 million in (unaudited) revenue

• Entered into a securities purchase agreement for the issuance and sale of securities for up to $10M under a new convertible preferred stock transaction. The consideration, consisting of a combination of cash and transferred securities, was valued at $1.00 per share

• Announced the launch of a company-wide incentive and recognition program, which provides vital new engagement tools and offers new avenues to wealth for all employees across their clinic network

• Integrated a new artificial intelligence (AI) platform in partnership with leading software provider Covetrus into the Company’s medical software. The Company believes this is the only AI platform being offered among publicly traded veterinary clinic networks

• Acquired 100% ownership interest in one animal hospital located in central Florida (DeBary). The acquisition is expected to add up to approximately $1.8 million in (unaudited) revenue, and brings the Company’s Florida holdings up to 5 clinics

• For the second quarter of 2025, total revenue was approximately $4.3 million, a decrease of 2% from the prior year period but an increase of 20% from Q1 2025. Comparable clinic revenues increased 5.7% from the prior year period.

Second Quarter 2025 Operational Highlights

• Entered an exclusive, non-binding Letter of Intent to acquire 100% ownership interest in one animal hospital located in New Jersey. Once completed, the acquisition could potentially add up to approximately $2.0 million in (unaudited) revenue

• Entered into a securities purchase agreement for the issuance and sale of securities for up to $10M under a new convertible preferred stock transaction. The consideration, consisting of a combination of cash and transferred securities, was valued at $1.00 per share

• Announced the launch of a company-wide incentive and recognition program, which provides vital new engagement tools and offers new avenues to wealth for all employees across their clinic network

• Integrated a new artificial intelligence (AI) platform in partnership with leading software provider Covetrus into the Company’s medical software. The Company believes this is the only AI platform being offered among publicly traded veterinary clinic networks

• Acquired 100% ownership interest in one animal hospital located in central Florida (DeBary). The acquisition is expected to add up to approximately $1.8 million in (unaudited) revenue, and brings the Company’s Florida holdings up to 5 clinics

Executive Commentary

“During the second quarter of 2025, we started to see the rewards of our new initiatives, processes, and hard work over the past 18 months with sequential revenue growth of 20% and year over year organic growth of 5.7%.,” said Kimball Carr, Inspire ‘s Chairman, President and Chief Executive Officer. “We also grew our portfolio of clinics to 14 with the recently announced acquisition in Florida while significantly improving our liquidity and capital structure with the recently announced preferred stock transaction. I believe this quarter will mark the turning point for our business model and that our top line growth will accelerate going forward.

Second Quarter 2025 Financial Overview

All comparisons are made relative to the same period in 2024 unless otherwise stated.

• Net loss for the first quarter of 2025 decreased $352,000, or 10%, to $3.0 million. The decline in net loss is primarily attributable to the reduction of interest expense and the exclusion of the operating expenses associated with KVC.

Balance Sheet

As of June 30, 2025, the Company had cash and cash equivalents of approximately $0.2 million.

About Inspire Veterinary Partners, Inc.

Inspire Veterinary Partners is an owner and provider of pet health care services throughout the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care.

For more information, please visit: www.inspirevet.com.

Connect with Inspire Veterinary Partners, Inc.

Facebook

https://www.facebook.com/InspireVeterinaryPartners/

LinkedIn

https://www.linkedin.com/company/inspire-veterinary-partners/

Forward-Looking Statements

This press release includes certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding management’s expectations of future financial and operational performance and expected growth and business outlook. These forward-looking statements include, but are not limited to, plans, objectives, expectations and intentions and other statements contained in this press release that are not historical facts and statements identified by words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” or words of similar meaning. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control including, without limitation, risks associated with our limited operating history and history of losses; our ability to continue operating as a going concern; our ability to raise additional capital; our ability to complete additional acquisitions; our ability to recruit and retain skilled veterinarians; our ability to retain existing customers and add new customers; the continued growth of the market in which we operate; our ability to manage our growth effectively over the long-term to maintain our high level of service; the price volatility of our Class A common stock; our ability to continue to have our Class A common stock listed on the Nasdaq Stock Market; the impact of geopolitical conflicts, inflation, and macroeconomic instability on our business, the broader economy, and our ability to forecast our future financial performance; and other risks set forth under the caption “Risk Factors” in our SEC filings. We assume no obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Investors
CoreIR
516-386-0430

General Inquiries
Morgan Wood
Mwood@inspirevet.com

Inspire Veterinary Partners, Inc. and Subsidiaries
Consolidated Balance Sheet

Inspire Veterinary Partners, Inc. and Subsidiaries
Consolidated Statements of Operation

Inspire Veterinary Partners, Inc. and Subsidiaries
Consolidated Statements of Cash Flows

SOURCE: INSPIRE VETERINARY PARTNERS, INC.

View the original press release on ACCESS Newswire

• Exclusive Letter of Intent for West Coast distribution of Nimbus Boats USA

• Expands Nautical Ventures’ lineup with premium Scandinavian‑designed models

• Strategic step to broaden Vision Marine’s portfolio after acquiring Nautical Ventures

• Enhances choice and experience for boaters in Florida’s top market

FORT LAUDERDALE, FL / ACCESS Newswire / August 14, 2025 / Vision Marine Technologies Inc. (NASDAQ:VMAR) (“Vision Marine” or the “Company”), a leader in premium on‑water experiences and the owner of Florida‑based dealership network Nautical Ventures, today announced that Nautical Ventures has entered into a Letter of Intent with Nimbus Boats USA to exclusively distribute Nimbus powerboats on Florida’s West Coast.

Nimbus’s Tender, Commuter, Weekender and Coupe series are recognized worldwide for their Scandinavian design, versatile layouts and meticulous construction. With more than seventy years of heritage, Nimbus is one of the respected powerboat builders in Europe and North America, and the largest Scandinavian boat builders by volume. Upon entering into definitive agreements, which the parties expect to conclude by March 31, 2026, Nautical Ventures would be authorized to promote, sell and service these models in Florida’s West Coast region beginning August 1, 2025.

“Adding Nimbus to our lineup will be a strategic move to broaden our product portfolio and serve customers who are seeking premium day‑cruiser and weekender boats,” said Alexandre Mongeon, Co‑Founder and Chief Executive Officer of Vision Marine. “Our vision is to curate the best selection of boats on the market and deliver an elevated on‑water experience. This partnership will expand our reach in Florida, leverage the sales and service capabilities of Nautical Ventures and align with our plan to build a diversified portfolio that addresses high‑margin segments. We believe it will position us to capitalize on strong consumer demand and favourable market trends, while continuing to support and grow our existing brand relationships.”

Industry data underpins the commercial rationale for the partnership. Boating and fishing contribute roughly $1.2 trillion to the U.S. outdoor recreation economy and support more than 812,000 jobs [1]. Florida is the largest market for new powerboats, engines and accessories, generating $6.4 billion in sales in 2023, a 3.1 percent increase over the prior year [2]. The National Marine Manufacturers Association projects that new powerboat sales will rebound in 2025, with total boating expenditures expected to rise 3-5 percent above 2024’s record levels [3]. Adventure‑style boats-versatile models designed for day trips, water sports and island hopping-are among the fastest‑growing categories in recreational boating, and Nimbus’s Tender, Commuter, Weekender and Coupe series are squarely in this segment. These trends suggest a sizable and resilient addressable market for high‑quality day boats and weekenders [4].

[1] https://www.bea.gov/
[2] www.marinadockage.com/
[3] https://boatingindustry.com/
[4] U.S. boating and outdoor recreation statistics sourced from the National Marine Manufacturers Association and the U.S. Bureau of Economic Analysis. See NMMA press release “Innovation Driving U.S. Boat Sales Demand As Key Winter Boat Show Buying Season Gets Underway” (https://www.nmma.org/press/article/24937) and Boating Industry article “NMMA shares 2024 U.S. boat sales stats” (https://boatingindustry.com/news/2025/01/14/nmma-shares-2024-u-s-boat-sales-stats/) for projections on powerboat sales. Adventure‑style boat trend commentary reflects general market observations and is not tied to a specific citation.

The Nimbus partnership is one of several initiatives Vision Marine is pursuing as it structures and expands its brand portfolio under new leadership. In June 2025, the Company acquired Nautical Ventures, a Florida‑based recreational boat dealership, marina and service provider widely recognized as one of the top networks in the United States and the number‑one Axopar dealership worldwide. Nautical Ventures operates nine high‑volume retail locations across Florida and distributes a diverse range of premium brands- including Axopar, Beneteau, Brabus, Edgewater, Highfield, NorthStar, Smokercraft, Wellcraft -serving customers from pontoons to luxury yacht owners. The acquisition created North America’s first electric boat propulsion and multi‑brand retail company, combining Vision Marine’s high‑voltage E‑Motion™ powertrain and electric boats with Nautical Ventures’ established sales and service infrastructure. Integrating Nimbus into this platform is part of a broader strategy to offer consumers the best products across propulsion types while supporting long‑term growth for all brands in the Nautical Ventures family.

About Vision Marine

Vision Marine Technologies Inc. (NASDAQ:VMAR) is a leader in high‑performance electric propulsion systems and premium boating experiences. The Company’s proprietary E‑Motion™ 180 horsepower electric outboard is the first high‑voltage system purpose‑built for the marine industry. In June 2025 Vision Marine acquired Nautical Ventures, creating North America’s first electric propulsion and multi‑brand boat retail company. The combined entity operates nine retail locations across Florida and distributes a wide range of prestigious boating brands. By uniting advanced technology with established sales and service infrastructure, Vision Marine aims to accelerate adoption of cleaner, high‑performance boating and provide consumers with an unmatched on‑water experience.

About Nimbus Boats USA

Nimbus Boats USA is the American arm of Nimbus Group, a global leader in the design and manufacture of luxury powerboats. With more than seventy years of heritage, Nimbus has earned a reputation for quality, safety, and innovation, and is the largest Scandinavian boat builder by volume. Its award-winning Tender, Commuter, Weekender, and Coupe series are sold through an extensive international dealer network spanning more than fifty countries. [5].

[5] Nimbus Boats USA information derived from company disclosures and publicly available sources, including Nimbus Group corporate materials.

Forward‑Looking Statement

Certain statements in this press release may constitute “forward‑looking statements” within the meaning of U.S. federal securities laws. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Forward‑looking statements include, among others, statements regarding the expected terms and timing of the definitive distribution agreement with Nimbus Boats USA, anticipated benefits of the partnership, projected market opportunities and Vision Marine’s strategic outlook. Factors that could affect actual results are detailed in the “Risk Factors” section of Vision Marine’s filings with the U.S. Securities and Exchange Commission. Vision Marine undertakes no obligation to update or revise any forward‑looking statements, except as required by law.

Investor and Company Contact:
Bruce Nurse
Investor Relations
(303) 919‑2913
bn@v‑mti.com

SOURCE: Vision Marine Technologies Inc

View the original press release on ACCESS Newswire

Dr. Gruber provides a guide for surgeon evaluation alongside complication prevention strategies and domestic alternative options which patients should consider.

TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Dr. Meegan Gruber, MD, PhD, who serves as a Board-Certified Plastic Surgeon warns patients to research all safety aspects of surgical tourism prior to scheduling foreign procedures. Each year approximately 150,000 to 320,000 U.S. citizens choose to get medical treatment abroad for cosmetic surgery operations which presents multiple medical and practical and legal dangers to patients when not properly organized.

The appeal of low costs and immediate appointment availability together with eye-catching before-and-after images motivates Dr. Gruber. “But surgery is not a vacation. The choice of surgical location and your operating doctor along with your preoperative and postoperative care management process matters equally to the surgical procedure itself.

Five risks patients often underestimate

• Drug-resistant infections. Medical facilities with poor sterilization methods and insufficient oversight have caused difficult to treat infection outbreaks during surgical procedures. The verification process of infection control standards and development of concrete follow-up plans stands as an essential requirement.

• Travel + surgery = clot risk. The combination of body contouring surgery with extended periods of travel by flight or car increases the chances of developing DVT/PE. Your surgeon must advise you to spend recovery time in the hospital before traveling home.

• Credentials and facilities vary. American Board of Plastic Surgery (ABPS) certification stands as the specialty standard because ABMS recognizes it in the United States. The addition of hospital OR credentialing with AAAHC or QUAD A facility accreditation enhances patient safety standards.

• Continuity-of-care gaps. Local physicians face delays in treating complications because they do not have access to your operative records or implant details which results in increased costs.

• Limited legal and financial recourse. The different legal systems of various countries create obstacles to resolving problems because each jurisdiction has its own approach to medical malpractice and device monitoring and patient safeguards.

A quick safety checklist from Dr. Gruber

• Check if the surgeon holds ABPS certification and matches their name and specialty while asking about their experience performing your target procedure.

• Verify that your medical facility holds accreditation from AAAHC or QUAD A or hospital OR status and that emergency procedures are in place.

• The anesthesiology details must be confirmed together with information about who will provide the anesthesia. Local anesthesia is suitable for qualified patients but general anesthesia is safer in certain cases and full information about the plan should be provided.

• Your recovery period needs to be planned to reduce blood clot risks as well as get medical clearance before departing.

• Before your trip you need to arrange follow-up care through defining the number of visits and weekend/night coverage and establishing what will happen during urgent medical situations.

Safer alternatives, without crossing borders

High-quality care performed domestically near patients’ homes provides the safest option when patients need full continuity of medical services before and after surgery. The patients at Gruber Plastic Surgery undergo candidacy screening and receive photography-guided planning and meticulous aftercare services. Local-anesthesia patients maintain continuous communication with their healthcare team during surgical procedures and general anesthesia patients receive detailed preoperative and postoperative monitoring plans. The Out of Town Patient Guide at our practice assists patients who travel within the United States to organize safe medical itineraries with suitable recovery periods and postoperative appointments.

A word from Dr. Gruber

“Prioritize safety over savings. Patients must verify professional credentials while selecting facilities that have received accreditation and they need to allow sufficient time for safe recovery. When you are not sure about something, request a second medical opinion. Our team along with I provide risk-focused consults to help you make well-informed decisions with confidence.”
About Gruber Plastic Surgery

Gruber Plastic Surgery, located in Tampa, FL, is led by Dr. Meegan Gruber, Ph.D., board-certified plastic surgeon renowned for her pioneering work in awake plastic surgery. Dr. Gruber, also the star of “Awake Surgery,” which you can stream today on TLC GO, HBO MAX, Hulu, Discovery+, and other streaming platforms, integrates advanced techniques and cutting-edge technology to deliver safe, comfortable, and natural-looking results with minimized recovery time. Specializing in awake surgeries, the clinic offers a range of state-of-the-art procedures. Dr. Gruber is committed to innovation and education, ensuring precision and safety in every treatment, while enhancing patient confidence through individualized care and surgical expertise.

Contact Information

Jay Saint
info@drmeegangruber.com
888-400-0086

SOURCE: Gruber Plastic Surgery

Related Images

View the original press release on ACCESS Newswire

Providing high-fidelity, live mission training capabilities for advanced weapons and tactics training

SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Cubic Defense, the world’s leading provider of advanced air combat training, announces the IDIQ contract award by the USAF for activities relating to the procurement, integration, deployment and sustainment of the entire P5 Combat Training Systems (P5CTS) inventory.

“Our P5CTS is designed to provide users with live mission training capabilities for advanced weapons and tactics training,” stated Russ Marsh, President, Cubic Defense. “The system features real-time air-to-air and air-to-ground weapons simulations and live monitoring capabilities. With the recent addition of the P5 Security Subsystem Upgrade (P5 SSU) to enable fully interoperable encrypted Time Space Position Information with Coalition 5^th Generation aircraft, Cubic and its partners are continuing to invest and deliver upgrades to the P5 CTS infrastructure to preserve customer investments in authentic training.”

QATAR. 11.28.2023. Photo by Staff Sgt. Daniel Hernandez, USAF. DVIDS – Images –
Qatar Emiri Air Force F-15E Strike Eagles participate in Exercise Sky Shield.
Cubic’s P5 Combat Training System (P5CTS) seen under the wing.

Cubic, along with its principal subcontractor, Leonardo DRS, will be supporting all contractor activities relating to the procurement, integration, deployment, and sustainment. The P5CTS improves U.S. and coalition training used by the USAF, US Marine Corps, US Navy and coalition partners. The system permits the user to continuously relay time, space, position information (TSPI) of the aircraft during training exercises, allowing the warfighter to train as they fight on a common platform with coalition partners.

About Cubic

Cubic creates and delivers technology solutions in transportation that make people’s lives easier by simplifying their daily journeys, and defense capabilities that help promote mission success and safety for those who serve their nation. Led by our talented teams around the world, Cubic is driven to solve global challenges through innovation and service to our customers and partners.

Part of Cubic’s portfolio of businesses, Cubic Defense provides networked Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance and Reconnaissance (C5ISR) products and services and is a leading provider of live, virtual, constructive, and game-based training solutions for both U.S. and Allied Forces. These mission-inspired capabilities enable assured multi-domain access; converged digital intelligence; and superior readiness for defense, intelligence, security and commercial missions. For more information, visit: Cubic Defense.

Media Contacts:
Geri MacDonald
Cubic Defense
geri.macdonald@cubic.com

Touchdown PR for Cubic Defense:
Cubicdefense@touchdownpr.com

SOURCE: Cubic Defense

View the original press release on ACCESS Newswire

Recognition serves as a testament to AmeriLife’s unique approach to partnership that helps accelerate growth and innovation for insurance and financial services companies

CLEARWATER, FL / ACCESS Newswire / August 14, 2025 / AmeriLife, a leading provider of financial and insurance solutions, is proud to announce that four of its affiliate partners have been recognized on Inc. 5000’s 2025 list of the fastest-growing private companies in America. This prestigious honor underscores the exceptional growth and innovative spirit of these companies, which are integral to AmeriLife’s mission of empowering individuals to achieve financial security and well-being.

The four partners named to the Inc. 5000 list are:

1. Florida Financial Advisors– a full-service, comprehensive wealth management and financial planning firm and insurance brokerage dedicated to helping middle-market Americans grow and secure their wealth and achieve their retirement goals.

2. Hoffman Financial Group– a nationally recognized financial planning firm based in Atlanta.

3. Brookstone Capital Management– a leading SEC-registered investment Advisory (RIA) firm that offers a robust independent marketing and Turnkey Asset Management Platform (TAMP) to help advisors grow and build scalable, client-first practices.

4. Pinnacle Financial Services– one of the largest full-service health, life, annuity, and long-term care national marketing organizations, providing financial products and services for individuals, businesses, and their employees.

Florida Financial Advisors, Hoffman Financial Group, and Brookstone Capital Management sit within AmeriLife’s Wealth Group. These firms have consistently demonstrated their ability to provide exceptional financial advice and innovative solutions, helping clients navigate complex financial landscapes and achieve their long-term goals.

“The inclusion of Florida Financial Advisors, Hoffman Financial Group, and Brookstone Capital Management on the Inc. 5000 list is a remarkable achievement,” said Mike Vietri, Chief Distribution Officer for AmeriLife Wealth Group. “These firms have consistently delivered exceptional wealth management services, helping their clients achieve financial security and peace of mind. Their success is a reflection of their commitment to excellence and innovation, and we are honored to have them as part of our wealth distribution channel.”

Pinnacle Financial Services, part of AmeriLife’s Health Distribution, has been recognized for its commitment to delivering high-quality health insurance and financial services, ensuring that clients have the support they need to maintain their health and financial stability.

“We are incredibly proud of Pinnacle Financial Services for being named to the Inc. 5000 list,” said Scotty Elliott, AmeriLife’s Chief Distribution Officer for Health. “Their dedication to providing personalized health and financial solutions has not only driven their success but has also significantly impacted the lives of their clients. This recognition is a testament to their hard work and the value they bring to our community.”

AmeriLife’s Affiliate Partnership Program continues to support its companies’ success, offering a unique and powerful model for modern distribution of health and wealth solutions. The program allows partner firms to maintain their independence post-acquisition while being backed by one of the most sophisticated distribution networks in the nation. By leveraging AmeriLife’s extensive resources, technology, and market expertise, affiliate partners can focus on what they do best-serving their clients-while enjoying the benefits of a robust support system. This strategic alliance not only enhances operational efficiency but also drives significant growth and innovation, as evidenced by the remarkable achievements of these four companies.

The Inc. 5000 list is a highly respected ranking of the nation’s fastest-growing private companies, based on revenue growth over three years. This year’s list represents a diverse range of industries and highlights the resilience and adaptability of America’s entrepreneurial companies. To view all 2025 honorees, visit www.inc.com/inc5000.

About AmeriLife

AmeriLife’s strength lies in its mission: to provide insurance and retirement solutions that help people live longer, healthier lives. AmeriLife develops, markets, and distributes life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For over 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers through a national distribution network of over 300,000 agents, financial professionals, and more than 160 marketing organizations and insurance agencies. For more information, visit AmeriLife.com and follow AmeriLife on Facebook and LinkedIn.

Contact Information

Jeff Maldonado
Media Contact
media@amerilife.com

Alex Hyer
Corporate Development
corporatedevelopment@amerilife.com

SOURCE: AmeriLife

Related Images

View the original press release on ACCESS Newswire

FREDERICKSBURG, VIRGINIA / ACCESS Newswire / August 14, 2025 / In an extraordinary opportunity to change someone’s life through the power of words, the “Write Your Way Home” Contest officially launches on August 15, 2025, giving aspiring homeowners the chance to win a stunning $1.8 million luxury property located at 1200 Prince Edward Street in historic downtown Fredericksburg, Virginia.

The contest challenges entrants to submit a 250- to 500-word essay on the theme: “Why I Want to Live in Historic Downtown Fredericksburg.”

Submissions must be accompanied by a $200 entry fee and received no later than September 29, 2025-45 days after the contest opens.

This modern luxury house is steeped in local charm and architectural beauty and offers the winner a once-in-a-lifetime opportunity to become part of Fredericksburg’s rich cultural legacy.

According to Fredericksburg’s guidebook, the 40-block historic city is full of buildings, each with its own fascinating past. You may explore everything Fredericksburg has to offer by taking a horse-drawn carriage, trolley, or strolling tour. You may enjoy the city’s history and its many restaurants operated by celebrity chefs, art galleries, unique boutiques, and exciting events all year. “This isn’t just a contest to win a house,” said Laurie Webb, Executive Director of the Fredericksburg SPCA. “It’s an opportunity for someone to turn their passion for community, philanthropy, and history into a home-by telling a story that connects heart to place.”

How to Enter:

Write a compelling 250-500 word essay on why you want to live in historic downtown Fredericksburg.

Submit your essay along with a $200 entry fee.

Visit www.writeyourwayhome.net for full contest rules and entry details.

The winning essay will be selected based on originality, emotional impact, and alignment with the contest theme by a panel of independent judges. The probability of winning is 1:15,000-20,000. The contest requires a minimum number of entries. In the event that the contest has more than 15,000 entries, all funds raised above the minimum will be donated to the Fredericksburg Regional Food Bank and the Fredericksburg SPCA.

About Edward & Lewis, LLC

Edward and Lewis, LLC is a privately held real estate development and management company dedicated to delivering quality projects that blend innovation, functionality, and community value. We work to bring together specialized expertise in planning, construction oversight, and property management to ensure a seamless process from concept to completion.

Don’t miss this chance to write your way into a historic home-and a new chapter of your life.

For media inquiries, contact:
press@writeyourwayhome.net

About the Property:
Located at 1200 Prince Edward Street, this stately residence blends historic elegance with modern luxury. Nestled in the heart of Fredericksburg’s famed historic district, the home offers 5500 square feet of refined living space, modern luxury, and timeless architectural features.

Contact Information

Press Office
press@writeyourwayhome.net

SOURCE: Edward & Lewis

View the original press release on ACCESS Newswire

WATERLOO, ON / ACCESS Newswire / August 14, 2025 / CryoDragon Inc., a boutique creative studio based in Kitchener-Waterloo, has won the 2026 Consumer Choice Award in the Web Design category for the Waterloo Region. Known for delivering personalized, scientifically-informed digital solutions, the award highlights CryoDragon’s commitment to crafting responsive, accessible websites and robust branding packages that help clients across Canada stand out.

Since launching in 2015, CryoDragon has built a reputation for offering full-service web design, e-commerce development, AODA-compliant accessibility solutions, SEO optimization, and comprehensive branding support – from logo design to photography and scientific illustration. Their services are delivered entirely in-house by Craig Christoff and Brenda Lee, a husband-and-wife team that uses a wealth of knowledge and expertise from their experiences to ensure clients receive expert oversight and a consistent creative vision.

Custom Websites Tailored to Real Needs

CryoDragon designs and develops websites tailored to client goals – ranging from lead generation and brand storytelling to e-commerce sales and membership portals. Each project includes consultation, user-experience design, coding, content strategy, hosting, and maintenance. The studio’s hands-on, data-driven process helps businesses improve site traffic, engagement, and conversions.

“We don’t outsource anything,” says Craig. “Everything stays under our roof, ensuring quality, seamless communication, and no hidden costs.”

SEO, Accessibility & Ongoing Support

CryoDragon offers AODA-compliant website design, incorporating accessibility (WCAG 2.0 A-AAA), SEO enhancements, content planning, and post-launch monitoring. Their long-term hosting and maintenance packages include analytics reporting and timely updates to keep sites secure and optimized.

A Branding & Design Partner Across Industries

Beyond web work, CryoDragon provides cohesive branding solutions – logo creation, corporate print design, photography, videography, and scientific illustrations. Their clients range from local startups and nonprofits to national consultants, research institutions, and corporate enterprises.

Regional Reach, National Impact

While based in Kitchener-Waterloo, CryoDragon has completed projects throughout Southwestern Ontario (Guelph, Cambridge, Hamilton) and across Canada – from Vancouver to Halifax. Their client roster includes the Biophysical Society of Canada, StrongPoint Automation, and HP Gas MRI Lab.

Clients praise their responsive communication, attention to detail, and professionalism:

“CryoDragon is a rare company… informative, highly responsive, incredibly patient and charitable… we gained a partner.” – Argus

“Prompt and professional… delivered on time… outstanding work and commitment.” – Biophysical Society of Canada

Trusted & Accredited Studio

CryoDragon is accredited by the Better Business Bureau with an A+ rating, reflecting its commitment to trust and transparency. Their Consumer Choice Award win further validates their excellence in client satisfaction, service quality, and local reputation – selected through an independent research process that includes customer surveys and brand reputation analysis. Their small-team approach makes them flexible, affordable, and deeply invested in each client’s success.

Commitment That Fuels Creativity

This award reflects CryoDragon’s dedication to delivering creative excellence, scientific rigor, and client-focused service. Their responsive design, accessible builds, and brand strategy help businesses thrive online, while their honest pricing and strong communication build lasting relationships.

“We view every project as a partnership,” says Brenda Lee. “We bring creativity, technical skill – and genuine care – to help your brand stand out.”

To learn more about CryoDragon’s award-winning digital and branding services, visit cryodragon.ca or explore their CCA Profile.

About CryoDragon Inc.
Founded in 2015, CryoDragon is a full-service creative studio based in Kitchener-Waterloo, with services across Southwestern Ontario and Canada. The in-house team offers website design and development, e-commerce, SEO, AODA-compliant accessibility, branding, graphic design, photography, videography, and scientific illustration – all driven by data and creative thinking. Accredited by the BBB with an A+ rating.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

CAMBRIDGE, ON / ACCESS Newswire / August 14, 2025 / Straight Street Event Services is proud to announce its selection as the 2026 Consumer Choice Award Winner for Audio Visual Services in Waterloo Region. This recognition reflects the trust placed in the company by local clients and partners, and highlights Straight Street’s ongoing commitment to delivering exceptional live event production – made easy.

Locally owned and operated, Straight Street specializes in full-service audiovisual support for live events of all shapes and sizes, combining over 30 years of technical expertise with a hands-on, customer-first approach that keeps clients coming back.

Built on Trust. Backed by Experience. Focused on You.

From one-night-only performances to corporate event, ice shows, fundraisers, and festivals, Straight Street brings every event to life with confidence, clarity, and calm. Their approach is simple: open communication, transparent budgets, and no unnecessary upselling – just reliable service from a team that knows what they’re doing.

“Winning the Consumer Choice Award is incredibly meaningful to us because it’s a reflection of our community’s confidence in what we do,” said Keith Kissner, Owner of Straight Street Event Services. “Our team works hard to make every client feel heard, every show be seamless, and every challenge feel easy. This award is a shared celebration of that philosophy.”

Technical Expertise. Personal Touch.

Straight Street provides complete audiovisual production, whether you’re hosting a meeting for ten or a gala for hundreds, or an outdoor event for thousands. Services include:

• Audio – Crystal-clear sound for speeches, music, and full productions

• Video – Projection, multi-camera live streaming, playback, and recording

• Lighting – From theatrical stage design to atmospheric event lighting

• AV Rentals – Fully supported gear packages for every venue and budget

• On-Site Support – Professional, proactive techs that keep your event running smoothly

Each solution is customized – not pulled off the shelf. Clients appreciate Straight Street’s dedication to making the process as smooth as the final show.

More Than Just Tech

What sets Straight Street apart isn’t just their gear – it’s their grounded, human approach. Clients receive honest advice, detailed planning, and on-site execution that makes everyone involved feel at ease.

That’s why event planners, producers, venues, schools, and municipalities and organizations across the region continue to trust Straight Street, year after year.

Proudly Serving Waterloo Region and Beyond

Located in Cambridge with work that stretches throughout Southern Ontario, Straight Street remains committed to supporting the communities it serves while delivering professional AV services that feel easy – and make a big impact.

Looking Ahead

As live events continue to evolve, Straight Street is investing in next-generation technologies for virtual and hybrid productions, expanding its equipment lineup, and mentoring the next wave of AV talent – all while staying grounded in the same values that have defined the company since day one.

Because at Straight Street, we don’t just produce shows – we make the process easy, the experience memorable, and the results something to be proud of.

To learn more about Straight Street Event Services or to request a quote, visit www.straightst.com.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire